LinkedIn Profile

Access Stemgent historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:stemgent 345803 Jun 3rd, 2019 12:00AM Stemgent, Inc. 1.3K 16.00 Open Biotechnology Jun 3rd, 2019 12:31PM Jun 3rd, 2019 12:31PM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Open mRNA reprogramming systems and services, Reagents for pluripotent cell culture and differentiation, Global supplier of human tissue and biofluids, Target and biomarker validation services, Compound profiling services in cell-based assays Open 4 Hartwell Place Lexington MA US 02421 Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 17th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 16th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 15th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 14th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 13th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 12th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 11th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 10th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology
private:stemgent 345803 Feb 9th, 2018 12:00AM Stemgent, Inc. 1.2K 19.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Stemgent, part of the ReproCELL Group, is a leading supplier of cellular reprogramming products and services and tissue-based research, and provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions. Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.